Who Exports Ibuprofen from India — 762 Suppliers Behind a $584.2M Market
India's ibuprofen export market is supplied by 762 active exporters who collectively shipped $584.2M across 15,000 shipments. MYLAN LABORATORIES LIMITED leads with a 22.8% market share, followed by GRANULES INDIA LIMITED and CAPLIN POINT LABORATORIES LIMITED. The top 5 suppliers together control 59.5% of total export value, reflecting a moderately competitive market structure.
Top Ibuprofen Exporters from India — Ranked by Export Value
MYLAN LABORATORIES LIMITED is the leading ibuprofen exporter from India, holding a 22.8% share of the $584.2M market across 15,000 shipments from 762 exporters. The top 5 suppliers — MYLAN LABORATORIES LIMITED, GRANULES INDIA LIMITED, CAPLIN POINT LABORATORIES LIMITED, MARKSANS PHARMA LIMITED, STRIDES PHARMA SCIENCE LIMITED — collectively control 59.5% of total export value, indicating a moderately concentrated market. Individual shares are: MYLAN LABORATORIES LIMITED (22.8%), GRANULES INDIA LIMITED (10.8%), CAPLIN POINT LABORATORIES LIMITED (9.3%), MARKSANS PHARMA LIMITED (9.2%), STRIDES PHARMA SCIENCE LIMITED (7.4%).
Top Ibuprofen Exporters from India
Ranked by export value · 762 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED IBUPROFEN TABLETS 400 MGHARMLESS MEDICINES, IBUPROFEN LYSINE TABIBUPROFEN LYSINE TABLETS 684MG (PACKS | $133.1M | 3 | 22.8% |
| 2 | GRANULES INDIA LIMITED IBUPROFEN TABLETS USP 400MGIBUPROFEN TABLETS USP 400MG (22025 X 100IBUPROFEN TABLETS USP 200MG ROUND | $63.3M | 11 | 10.8% |
| 3 | CAPLIN POINT LABORATORIES LIMITED IBUPROFEN TABLETS 400 MGIBUWIN GEL CAPS 600 (IBUPROFEN SOFT GELAIBUPROFEN TABLETS BP 800MG | $54.3M | 9 | 9.3% |
| 4 | MARKSANS PHARMA LIMITED NUROFEN IBUPROFEN EXTENDED RELEASE TABLEIBUPROFEN TABLETS USP 400MGIBUPROFEN TABLETS USP 400MG (22025 X 100 | $53.8M | 8 | 9.2% |
| 5 | STRIDES PHARMA SCIENCE LIMITED NUROFEN IBUPROFEN EXTENDED RELEASE TABLEIBUPROFEN TABLETS USP 400MGIBUPROFEN TABLETS USP 400MG (22025 X 100 | $43.3M | 8 | 7.4% |
| 6 | WOCKHARDT LIMITED PHARMACEUTICAL PRODUCTS-IBUPROFEN 200MGPHARMACEUTICAL PRODUCTS-IBUPROFEN SOFT G | $37.1M | 1 | 6.4% |
| 7 | AUROBINDO PHARMA LTD IBUPROFEN TABLETS 400 MGIBUPROFEN TABLETS USP 200MG ROUNDPHARMACEUTICAL PRODUCTS-IBUPROFEN TABLET | $10.1M | 6 | 1.7% |
| 8 | MEDREICH LIMITED IBUPROFEN TABLETS 400 MGNUROFEN IBUPROFEN EXTENDED RELEASE TABLEPARACETAMOL 325MG ,IBUPROFEN 200MG AND C | $9.9M | 7 | 1.7% |
| 9 | ALKEM LABORATORIES LIMITED NUROFEN IBUPROFEN EXTENDED RELEASE TABLEIBUPROFEN TABLETS USP 200MG ROUNDPHARMACEUTICAL PRODUCTS-IBUPROFEN TABLET | $9.2M | 8 | 1.6% |
| 10 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED IBUPROFEN TABLETS BP 800MGPHARMACEUTICAL PRODUCTS-IBUPROFEN 200MGIBUWIN 600 IBUPROFEN SOFT GELATIN CAPSULES 600MG | $7.6M | 18 | 1.3% |
| 11 | VIVIMED LIFE SCIENCES PRIVATE LIMITED IBUPROFEN TABLETS USP 200MG ROUNDPHARMACEUTICAL PRODUCTS-IBUPROFEN TABLETIBUPROFEN TABLETS 800 MG | $6.7M | 1 | 1.2% |
| 12 | WEXFORD LABORATORIES PRIVATE LIMITED IBUWIN GEL CAPS 600 (IBUPROFEN SOFT GELAIBUPROFEN TABLETS BP 800MGIBUPROFEN TABLETS BP 400MG | $6.5M | 5 | 1.1% |
| 13 | IPCA LABORATORIES LIMITED NUROFEN IBUPROFEN EXTENDED RELEASE TABLEIBUPROFEN ROUND SHAPED TABS BP 200MG BATIBUPROFEN SOFT GELATIN CAPSULES 200 MG B | $6.0M | 7 | 1.0% |
| 14 | QUALIGENS PHARMA PRIVATE LIMITED | $5.6M | 4 | 1.0% |
| 15 | ADCOCK INGRAM LIMITED IBUPROFEN TABLETS 200 MG B.PGESIC ADL 400 MGPACKK SIZE10X10'S | $5.5M | 1 | 0.9% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Ibuprofen exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| MYLAN LABORATORIES LIMITED | Warning Letter issued in | Yes, certified as of | Unknown | Multiple ANDAs approved, including Amphotericin B Liposome for Injection in June 2025. | FDA issued a Warning Letter to Mylan Laboratories Limited's Unit 7 facility on A |
| GRANULES INDIA LIMITED | Approved | Yes, certified as of | Unknown | Unknown | Granules India Limited holds WHO-GMP certification as of January 2019. |
| AUROBINDO PHARMA LTD | Warning Letter issued in | Yes, certified as of | Unknown | Multiple ANDAs approved, including Chlorzoxazone Tablets. | FDA issued a Warning Letter to Aurobindo Pharma Limited's Unit I facility on Jan |
| WOCKHARDT LIMITED | Unknown | Unknown | Unknown | Unknown | No FDA Warning Letters found for Wockhardt Limited. |
| ALKEM LABORATORIES LIMITED | Approved | Unknown | Unknown | Multiple ANDAs approved, including Prucalopride Tablets in June 2025. | Alkem Laboratories Limited received FDA approval for Prucalopride Tablets in Jun |
| STRIDES PHARMA SCIENCE LIMITED | Approved | Unknown | Unknown | Unknown | Strides Pharma Science Limited is an Indian pharmaceutical company headquartered |
| CAPLIN POINT LABORATORIES LIMITED | Unknown | Unknown | Unknown | Unknown | No FDA Warning Letters found for Caplin Point Laboratories Limited. |
| MARKSANS PHARMA LIMITED | Unknown | Unknown | Unknown | Unknown | No FDA Warning Letters found for Marksans Pharma Limited. |
| MEDREICH LIMITED | Unknown | Unknown | Unknown | Unknown | No FDA Warning Letters found for Medreich Limited. |
| FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED | Unknown | Unknown | Unknown | Unknown | No FDA Warning Letters found for Fourrts (India) Laboratories Private Limited. |
TransData Nexus reviewed the regulatory standing of 10 leading Ibuprofen exporters from India. 3 hold US FDA facility approvals, 3 maintain WHO-GMP certification, and 0 are EU GMP compliant. 2 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Ibuprofen sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for active pharmaceutical ingredient (API) production. The city hosts numerous API manufacturers, including Granules India Limited, which is headquartered in Hyderabad. Granules India is involved in the manufacture and sale of APIs, pharmaceutical formulation intermediates (PFIs), and finished dosage forms (FDs), including products such as paracetamol, metformin, and guaifenesin.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Companies like Alembic Pharmaceuticals, headquartered in Vadodara, specialize in the production of formulations for therapeutic areas such as cardiology, dermatology, diabetes, ophthalmology, and infectious diseases for domestic and international markets.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region serves as a critical export gateway for pharmaceutical products. This area is home to several pharmaceutical companies that leverage the proximity to major ports for efficient distribution. The region's infrastructure supports the export of ibuprofen and other pharmaceuticals to international markets.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, primarily due to favorable tax incentives. This area attracts numerous pharmaceutical companies seeking cost advantages in production.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Capabilities: Assess the manufacturing capabilities and compliance records of potential suppliers to ensure consistent quality and regulatory adherence.
- Leverage Export Infrastructure: Utilize suppliers in regions with robust export facilities, such as the Mumbai-Thane-Raigad cluster, to streamline logistics and reduce lead times.
- Monitor Regulatory Changes: Stay informed about tax incentives and regulatory developments in regions like Baddi-Nalagarh to capitalize on cost-saving opportunities.
By strategically sourcing from India's diverse pharmaceutical clusters, companies can optimize their supply chains for ibuprofen production and distribution.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Ibuprofen exporters from India
Strides Pharma Science Limited — Strides announces demerger of CDMO and Softgel businesses
On September 25, 2023, Strides Pharma Science Limited's board approved a Scheme of Arrangement to demerge its Contract Development and Manufacturing Organization (CDMO) and Softgel businesses. These units will merge with Stelis Biopharma Limited, with an appointed date of April 1, 2024. The scheme is subject to approvals from regulatory authorities, including the Securities and Exchange Board of India (SEBI) and the National Company Law Tribunal (NCLT). - IMPACT: This restructuring may streamline Strides' operations, potentially enhancing its focus on Ibuprofen production and export capabilities.
Impact: This restructuring may streamline Strides' operations, potentially enhancing its focus on Ibuprofen production and export capabilities.
Granules India Limited — Granules India reports cybersecurity breach
In June 2023, Granules India Limited experienced a cybersecurity incident, with the ransomware group LockBit claiming responsibility. The breach involved access to confidential data. - IMPACT: While the immediate impact on Ibuprofen exports is unclear, such breaches can disrupt operations and supply chains, potentially affecting export commitments.
Impact: While the immediate impact on Ibuprofen exports is unclear, such breaches can disrupt operations and supply chains, potentially affecting export commitments.
Caplin Point Laboratories Limited — Caplin Steriles secures ₹218 crore investment
In January 2019, Caplin Point Laboratories announced an investment in its injectables subsidiary, Caplin Steriles, by Eight Roads Ventures and F-Prime Capital. The investors committed a total of ₹218 crore in the form of compulsorily convertible preference shares. - IMPACT: This investment is expected to bolster Caplin's manufacturing capabilities, potentially enhancing its Ibuprofen production and export capacity.
Impact: This investment is expected to bolster Caplin's manufacturing capabilities, potentially enhancing its Ibuprofen production and export capacity.
Common Questions — Ibuprofen Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which ibuprofen supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, MYLAN LABORATORIES LIMITED leads with 184 recorded shipments worth $133.1M. GRANULES INDIA LIMITED (698 shipments) and CAPLIN POINT LABORATORIES LIMITED (627 shipments) are also established high-volume exporters.
Q How many ibuprofen manufacturers are there in India?
India has 762 active ibuprofen exporters with a combined export market of $584.2M across 15,000 shipments to 173 countries. The top 5 suppliers hold 59.5% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for ibuprofen from India?
Average FOB unit price: $4.72 per unit, ranging from $0.00 to $651.77. Average shipment value: $38.9K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 762 verified Indian exporters of Ibuprofen ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 15,000 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 173 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
15,000 Verified Shipments
762 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists